Glaxosmithkline Share News (GSK)

Glaxosmithkline Information

Buy GSK Shares
Add GSK to Watchlist
Add GSK to Alert

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 1,799.50

Bid: 1,796.00

Ask: 1,796.50

Change: 19.00 (1.07%)

Spread: 0.50 (0.028%)

Open: 1,784.00

High: 1,799.50

Low: 1,780.00

Prev. Close: 1,780.50

Last checked at -

12 May 2014 11:55

RPT-Fitch: 1Q14 European Big Pharma Dashboard

(Repeat for additional subscribers) May 12 (Reuters) - (The following statement was released by the rating agency) Fitch Ratings has published its 1Q14 European Big Pharma Dashboard. The publication explores major topics affecting issuer credit profiles for the sector in Europe

12 May 2014 05:10

UK Dividends Calendar - Week Ahead

UK Dividends Calendar

11 May 2014 16:00

Allergan rebuffed in seeking offers to combat Valeant bid-report

(Refiled to remove extraneous text characters in headline) May 11 (Reuters) - U.S. medical firm Allergan Inc declined to comment on Sunday on a report that it has been seeking offers from rival companies to combat Valeant Pharmaceuticals International's $47 billion cash and share offer.Read more

9 May 2014 15:13

UK Dividends Calendar - Week Ahead

UK Dividends Calendar

9 May 2014 05:26

UK Dividends Calendar - Week Ahead

UK Dividends Calendar

8 May 2014 15:40

GlaxoSmithKline Gains European Marketing Approval For Anoro Ellipta

LONDON (Alliance News) - GlaxoSmithKline PLC Thursday said that it has been granted marketing authorisation in Europe for Anoro Ellipta, as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease. Anoro Ellipta is a once-daily

8 May 2014 15:37

UK Dividends Calendar - Week Ahead

UK Dividends Calendar

8 May 2014 15:21

GlaxoSmithKline lung drug Anoro approved in Europe

LONDON, May 8 (Reuters) - GlaxoSmithKline said on Thursday its new inhaled lung drug, Anoro, had been approved in Europe as a treatment for chronic lung disease, boosting its respiratory franchise. A final green light had been expected for the product, which was developed with Theravance, f

8 May 2014 12:58

RPT-Fitch Revises Bayer AG'S Outlook to Negative; Affirms at 'A'

(Repeat for additional subscribers) May 8 (Reuters) - (The following statement was released by the rating agency) Fitch Ratings has revised Germany-based healthcare company Bayer AG's Outlook to Negative from Stable. The agency has also affirmed its Long-term Issuer Default Rating (ID

8 May 2014 05:30

RPT-In AstraZeneca fight, valuing drugs as much art as science

(Repeats Wednesday story with no changes) * AstraZeneca forecasts show variables in drug modelling * $45 bln sales prediction widely seen as over-optimistic By Ben Hirschler LONDON, May 7 (Reuters) - Ten-year sales forecasts from AstraZeneca - a central plank of its defenc

8 May 2014 05:12

UK Dividends Calendar - Week Ahead

7 May 2014 15:54

In AstraZeneca fight, valuing drugs as much art as science

* AstraZeneca forecasts show variables in drug modelling * $45 bln sales prediction widely seen as over-optimistic By Ben Hirschler LONDON, May 7 (Reuters) - Ten-year sales forecasts from AstraZeneca - a central plank of its defence against a $106 billion bid approach from Pfize

7 May 2014 15:49

UK Dividends Calendar - Week Ahead

UK Dividends Calendar

7 May 2014 11:28

BUZZ-Europe: what's hot, what's not

Round-up of the latest European equity market heat maps based on constituents for the Stoxx 600 : ** Year-to-date performance: http://link.reuters.com/tag98v ** German stocks remain the weakest except for significant outperformance from EM-exposed materials companies like ThyssenKrupp

7 May 2014 08:35

Wednesday broker round-up UPDATE

Balfour Beatty: Jefferies reduces target price from 403p to 233p downgrading to hold. Deutsche Bank cuts target price from 280p to 250p and leaves its hold recommendation unchanged. Numis reduces target price to 260p and retains an add rating. Barclays: Deutsche Bank lowers target price from 320p t

UK Dividends Calendar

Latest Share Chat

Glaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Login to your account

Quickpicks are a member only feature

Login to your account